Marker Therapeutics Inc (MRKR)

[Gatta-git-it]

Again, I repeat my appreciation for PL..
What concerns me is 2016 TPIV..trials in breast and ovarian cancer and suggested a few years for results,the same in 2017 and 2018..and 19 and 20.. thus far: Nothing.
Then came the merger and further studies in AML and then pancreatic cancer.. once again 2 years.. now: Nothing. But, we hear wait a few years.. really?
Other bios will eat our lunch. Our lunch will need to be funded (dilution) yet again.
The Golden touch brothers ( read the web site) even with inside communication exchanges pulled out.. not good in any view point.
Like all, third quarter reporting better have some solid, measurable good data, or this is headed for the dumper and likely a legal issue..
Challenge this all you want, but 5+ years have produced nothing.
We are blinded by management and science and only the " loyalists- those who invest mainly with " hope" keep the fires going. We need open transparency. Wow a $1.62.. says it all.